×

'Surprised' at value of Roche-Intermune deal: Pro

4:20 AM ET Mon, 25 Aug 2014

Surani Fernando, EMEA deputy editor at Biopharm Insight, says she was "surprised" at the value of Roche's $8.3 billion purchase of Intermune.